HAVN LIFE SCIENCES INC. (5NP0) - Net Assets

Latest as of : €- EUR ≈ $- USD

Based on the latest financial reports, HAVN LIFE SCIENCES INC. (5NP0) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore cash efficiency ratio of HAVN LIFE SCIENCES INC. to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€-
% of Total Assets	0%
Annual Growth Rate	-76.23%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	N/A

HAVN LIFE SCIENCES INC. - Net Assets Trend (2021–2022)

This chart illustrates how HAVN LIFE SCIENCES INC.'s net assets have evolved over time, based on quarterly financial data. Also explore HAVN LIFE SCIENCES INC. asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for HAVN LIFE SCIENCES INC. (2021–2022)

The table below shows the annual net assets of HAVN LIFE SCIENCES INC. from 2021 to 2022. For live valuation and market cap data, see 5NP0 stock market capitalisation.

Year	Net Assets	Change
2022-04-30	€3.14 Million ≈ $3.67 Million	-76.21%
2021-04-30	€13.20 Million ≈ $15.43 Million	--

Equity Component Analysis

This analysis shows how different components contribute to HAVN LIFE SCIENCES INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 2244354800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (April 2022)

Component	Amount	Percentage
Other Components	€56.01 Million	1783.10%
Total Equity	€3.14 Million	100.00%

HAVN LIFE SCIENCES INC. Competitors by Market Cap

The table below lists competitors of HAVN LIFE SCIENCES INC. ranked by their market capitalization.

Company	Market Cap
Haydale Graphene Industries LSE:HAYD	$173.57K
Lexington Gold Ltd LSE:LEX	$173.59K
ImagineAR Inc F:GMS1	$173.97K
Kalium Lakes Ltd AU:KLL	$174.54K
Ingenta plc LSE:ING	$172.13K
Oriole Resources PLC LSE:ORR	$171.92K
Zinc Media Group LSE:ZIN	$170.18K
Afine Investments Ltd JSE:ANI	$169.62K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in HAVN LIFE SCIENCES INC.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2021 to 2022, total equity changed from 13,199,908 to 3,140,917, a change of -10,058,991 (-76.2%).
Net loss of 22,443,548 reduced equity.
New share issuances of 1,999,755 increased equity.
Other factors increased equity by 10,384,802.

Equity Change Factors (2021 to 2022)

Factor	Impact	Contribution
Net Income	€-22.44 Million	-714.55%
Share Issuances	€2.00 Million	+63.67%
Other Changes	€10.38 Million	+330.63%
Total Change	€-	-76.21%

Book Value vs Market Value Analysis

This analysis compares HAVN LIFE SCIENCES INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.02x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2021-04-30	€3.68	€0.01	x
2022-04-30	€0.62	€0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently HAVN LIFE SCIENCES INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -714.55%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -8117.81%
• Asset Turnover: 0.07x
• Equity Multiplier: 1.29x
Recent ROE (-714.55%) is below the historical average (-472.36%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2021	-230.16%	0.00%	0.00x	1.08x	€-31.70 Million
2022	-714.55%	-8117.81%	0.07x	1.29x	€-22.76 Million

Industry Comparison

This section compares HAVN LIFE SCIENCES INC.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $223,512,703
Average return on equity (ROE) among peers: -29.10%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
HAVN LIFE SCIENCES INC. (5NP0)	€-	-230.16%	N/A	$172.31K
PROQR THERAPEUTICS EO-04 (0PQ)	$49.37 Million	-85.44%	1.28x	$142.34 Million
TIZIANA LIFE SCIENCES LTD (0RP)	$41.28 Million	-56.73%	0.18x	$161.62 Million
Theravance Biopharma Inc (0TB)	$-303.75 Million	0.00%	0.00x	$823.46 Million
I-MAB SPONS.ADS/1 -0001 (0VY)	$715.33 Million	-51.14%	0.23x	$212.27 Million
PreveCeutical Medical Inc (18H)	$-4.49 Million	0.00%	0.00x	$3.34 Million
Argen-X (1AE)	$344.93 Million	-8.14%	0.08x	$41.67 Billion
WAVE LIFE SCIENCES LTD. (1U5)	$518.36 Million	-39.43%	0.23x	$1.14 Billion
BIOCURE TECHNOLOGY INC. (1WH)	$1.34 Million	-19.58%	0.49x	$960.84K
ZAI LAB LTD0000006 (1ZLB)	$840.90 Million	-30.57%	0.41x	$1.82 Billion
BioNTech SE (22UA)	$31.86 Million	0.00%	11.24x	$20.05 Billion

About HAVN LIFE SCIENCES INC.

F:5NP0 Germany Biotechnology

Market Cap

$172.31K

€147.39K EUR

Market Cap Rank

#31051 Global

#2790 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.01 - €0.01

All Time High

€26.34